Laura Gault
Directeur Technique/Scientifique/R&D chez SAGE THERAPEUTICS, INC.
Fortune : 3 083 $ au 30/04/2024
Postes actifs de Laura Gault
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SAGE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/10/2022 | - |
Historique de carrière de Laura Gault
Anciens postes connus de Laura Gault
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2019 | 01/11/2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/01/2017 | 01/03/2019 |
Formation de Laura Gault
| Case Western Reserve University | Doctorate Degree |
| University of Pittsburgh | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Laura Gault
- Expérience